![Chandra Paul Leo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 242 000 $ in data 30/06/2026
Dr. Chandra Paul Leo is an Independent Director at Monte Rosa Therapeutics, Inc. and an Investment Advisor Private Equity at HBM Partners AG.
He is on the Board of Directors at Monte Rosa Therapeutics, Inc., Galecto Biotech ApS, Dren Bio, Inc., Fore Biotherapeutics, Inc., Gynesonics, Inc., i-Optics BV, River 2 Renal Corp.
and River 3 Renal Corp.
Dr. Leo was previously employed as a Vice Chairman by Cell Medica Switzerland AG and a Principal by Wellington Partners GmbH.
He also served on the board at Longboard Pharmaceuticals, Inc., Damora Therapeutics, Inc., CardiacAssist, Inc., ChemoCentryx, Inc., ESBATech, a Novartis Co. GmbH, Homology Medicines, Inc., ObsEva SA and Symbiomix Therapeutics LLC.
He received his graduate degree from the University of Basel, an MBA from INSEAD and a doctorate degree from Freie Universität Berlin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/03/2025 | 10.000 ( 0,01% ) | 242 000 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/09/2020 |
River 2 Renal Corp.
 River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapies targeting orphan diseases in the renal space | Direttore/Membro del Consiglio | - |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Direttore/Membro del Consiglio | - |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Direttore/Membro del Consiglio | - |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Analista di Private Equity | 01/01/2007 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Direttore/Membro del Consiglio | 26/10/2018 |
i-Optics BV
 i-Optics BV Medical SpecialtiesHealth Technology Develops and produces eye diagnosis and therapeutic solutions | Direttore/Membro del Consiglio | - |
Gynesonics, Inc.
 Gynesonics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for diagnostic intrauterine imaging and trans cervical treatment of symptomatic uterine fibroids | Direttore/Membro del Consiglio | - |
River 3 Renal Corp.
 River 3 Renal Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug development company for treating kidney diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 22 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Gynesonics, Inc.
Gynesonics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for diagnostic intrauterine imaging and trans cervical treatment of symptomatic uterine fibroids | Health Technology |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Health Technology |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
CardiacAssist, Inc.
 CardiacAssist, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
i-Optics BV
i-Optics BV Medical SpecialtiesHealth Technology Develops and produces eye diagnosis and therapeutic solutions | Health Technology |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products | Health Technology |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
River 2 Renal Corp.
River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapies targeting orphan diseases in the renal space | Health Technology |
River 3 Renal Corp.
River 3 Renal Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug development company for treating kidney diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
